86 results
8-K
EX-99.1
NMRD
Nemaura Medical Inc
3 Jan 24
Important Update on Listing Status and Strategic Direction
7:00am
to focus on long-term growth without the immediate pressures associated with maintaining a Nasdaq listing.
Strategic Partnerships:
Committed to creating
8-K
EX-99.1
NMRD
Nemaura Medical Inc
14 Nov 23
Regulation FD Disclosure
4:33pm
, such as statements about Nemaura’s short - term and long - term growth strategies, can sometimes be identified by use of terms such as “intend,” “expect
8-K
EX-99.1
s1yf4kiu vpdr6ppt5b
13 Sep 23
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
8:03am
424B8
xs6vtk62qel89 l9ow
11 Sep 23
Prospectus unintentially filed late
4:41pm
PRE 14A
nkv3t0fvz5lt9bv88tmr
10 Aug 23
Preliminary proxy
4:05pm
POS AM
oa91gikuh
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
424B4
21gn6ot aah0t0k
15 May 23
Prospectus supplement with pricing info
4:31pm
424B5
im6nxqqzy gmjkt
1 Apr 22
Prospectus supplement for primary offering
4:29pm